Clinical Trials on Breast Cancer Recurrent in Germany
Total 2639 results
-
European Organisation for Research and Treatment...TerminatedBreast CancerFrance, Belgium, Slovenia, Israel, United Kingdom, Germany, Austria
-
West German Study GroupEli Lilly and Company; Genomic Health®, Inc.RecruitingBreast Cancer FemaleGermany
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
Ludwig-Maximilians - University of MunichCompletedProstate Cancer | Urothelial Carcinoma | Renal Cell Cancer | Fear of Cancer Recurrence | Testicle CancerGermany
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
SOLTI Breast Cancer Research GroupEisai Inc.CompletedBreast CancerSpain, France, Portugal, Germany
-
Eli Lilly and CompanyCompletedBreast CancerItaly, Spain, Turkey, Germany, South Africa
-
Center for Epidemiology and Health Research, GermanyBayerCompletedBreast Cancer | Venous Thromboembolism | Arterial ThromboembolismGermany
-
West German Study GroupNovartis; Genomic Health®, Inc.Recruiting
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
San Antonio Military Medical CenterNuGenerex Immuno-Oncology; Norwell, Inc.CompletedBreast CancerUnited States, Germany, Greece
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Eli Lilly and CompanyCompletedBreast CancerArgentina, Belgium, Germany, Romania, Spain, United Kingdom
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
SanofiCompletedOvarian Cancer RecurrentBelgium, Russian Federation, Poland, Spain, Czech Republic, United States, France, Germany, Italy, Ukraine
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
European Organisation for Research and Treatment...Active, not recruitingBreast CancerItaly, Spain, Poland, Belgium, Jordan, United Kingdom, Netherlands, France, Germany, Switzerland
-
SanofiCompletedBreast CancerUnited States, France, Canada, Germany, Italy, Netherlands, Spain, Switzerland, Turkey, Belgium, Argentina, Denmark, Colombia, Korea, Republic of, South Africa
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)Completed
-
Center for Epidemiology and Health Research, GermanyAbbott Products Operations AGTerminatedEarly Pregnancy Bleeding | Recurrent Pregnancy LossGermany
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBreast CancerSpain, Poland, Italy, Austria, Russian Federation, Slovakia, Hungary, Germany, Czech Republic, Estonia, Latvia
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)Germany
-
AstraZenecaGerman Adjuvant Breast Cancer GroupCompleted
-
Pulsion Medical Systems SEUnknownMalignant Neoplasm of BreastGermany
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
AstraZenecaDaiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerUnited States, Italy, India, Taiwan, Germany, Korea, Republic of, Brazil, Poland, Russian Federation, Turkey, Spain, Australia, France, Canada, United Kingdom
-
AstraZenecaCompletedBreast CancerGermany, Norway, Austria
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
Dr. Horst Schmidt Klinik GmbHDeutsche Gesellschaft für hypnose und hypnotherapie E.V.TerminatedBreast Neoplasm | Ovary CancerGermany
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Eli Lilly and CompanyCompletedBreast CancerUnited States, Belgium, Spain, Germany, United Kingdom, France
-
Heinrich-Heine University, DuesseldorfUnknown
-
AbbVieTerminatedCancer | Breast CancerUnited States, Germany, Japan, Puerto Rico
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Poland, Portugal, United Kingdom, France, Canada, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Brazil, Colombia, Greece, Taiwan, Malaysia, Philippines, Austria, R... and more
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Charite University, Berlin, GermanyRecruiting